Search research articles
Contact Us
Filters
Showing results (31-40 of 136) with videos related to
Page
of 14
Sort By:
Molecular Therapy. Methods & Clinical Development
|
March 26, 2021
Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec
John W Day, Richard S Finkel, Eugenio Mercuri, et al.
American Journal of Human Genetics
|
September 25, 2003
Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract
Christina L Liquori, Yoshio Ikeda, Marcy Weatherspoon, et al.
Neurogenetics
|
December 7, 2007
Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families
Tsukasa Saito, Yoshinobu Amakusa, Takashi Kimura, et al.
Journal of Neurology
|
June 29, 2013
Diagnostic odyssey of patients with myotonic dystrophy
James E Hilbert, Tetsuo Ashizawa, John W Day, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 11, 2025
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility
Janel A M Peterson, Jesus A Frias, Andrew N Miller, et al.
Biotechnology Advances
|
November 19, 2003
Using ecotechnology to address water quality and wetland habitat loss problems in the Mississippi basin: a hierarchical approach
John W Day, Alejandro Yañéz Arancibia, William J Mitsch, et al.
Neuromuscular Disorders : NMD
|
March 6, 2014
Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy
Julien Couthouis, Alya R Raphael, Carly Siskind, et al.
Neurology. Genetics
|
April 12, 2016
Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy
Jeremy M Sullivan, Christina M Zimanyi, William Aisenberg, et al.
Drug Safety
|
August 12, 2021
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
John W Day, Jerry R Mendell, Eugenio Mercuri, et al.
Nature Cell Biology
|
July 9, 2013
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Foteini Mourkioti, Jackie Kustan, Peggy Kraft, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 136) with videos related to
Sort By:
Page
of 14
Molecular Therapy. Methods & Clinical Development
|
March 26, 2021
Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec
John W Day, Richard S Finkel, Eugenio Mercuri, et al.
American Journal of Human Genetics
|
September 25, 2003
Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract
Christina L Liquori, Yoshio Ikeda, Marcy Weatherspoon, et al.
Neurogenetics
|
December 7, 2007
Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families
Tsukasa Saito, Yoshinobu Amakusa, Takashi Kimura, et al.
Journal of Neurology
|
June 29, 2013
Diagnostic odyssey of patients with myotonic dystrophy
James E Hilbert, Tetsuo Ashizawa, John W Day, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 11, 2025
MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility
Janel A M Peterson, Jesus A Frias, Andrew N Miller, et al.
Biotechnology Advances
|
November 19, 2003
Using ecotechnology to address water quality and wetland habitat loss problems in the Mississippi basin: a hierarchical approach
John W Day, Alejandro Yañéz Arancibia, William J Mitsch, et al.
Neuromuscular Disorders : NMD
|
March 6, 2014
Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy
Julien Couthouis, Alya R Raphael, Carly Siskind, et al.
Neurology. Genetics
|
April 12, 2016
Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy
Jeremy M Sullivan, Christina M Zimanyi, William Aisenberg, et al.
Drug Safety
|
August 12, 2021
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
John W Day, Jerry R Mendell, Eugenio Mercuri, et al.
Nature Cell Biology
|
July 9, 2013
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Foteini Mourkioti, Jackie Kustan, Peggy Kraft, et al.
Page
of 14